ANTONAZZO IPPAZIO COSIMO

Antonazzo, I., Rozza, D., Cortesi, P., Fornari, C., Zanzottera Ferrari, E., Paris, C., et al. (2025). Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database. ACTA DIABETOLOGICA, 62(3), 343-351 [10.1007/s00592-024-02359-1]. Dettaglio

Ferrara, P., Monti, C., Rozza, D., Fornari, C., Antonazzo, I., Ferrara, M., et al. (2025). Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 37(1) [10.1007/s40520-025-03111-7]. Dettaglio

Antonazzo, I., Gribaudo, G., La Vecchia, A., Ferrara, P., Piraino, A., Cortesi, P., et al. (2024). Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review. PHARMACOECONOMICS, 42(12), 1329-1343 [10.1007/s40273-024-01428-1]. Dettaglio

Ponticelli, D., Antonazzo, I., Losa, L., Zampella, A., Di Marino, F., Mottola, G., et al. (2024). Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy. MEDICINA, 60(1) [10.3390/medicina60010093]. Dettaglio

Cortesi, P., Antonazzo, I., Palladino, P., Gnesi, M., Mele, S., D’Amelio, M., et al. (2024). Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis. ACTA DIABETOLOGICA, 61(8), 1017-1028 [10.1007/s00592-024-02276-3]. Dettaglio